Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06883227 · ClinicalTrials.gov registry record

Investigating Health Impacts of Exposure to Harmful Algal Blooms

A clinical trial of Neurologic Disorder and Red Tide, sponsored by Roskamp Institute.

Recruiting
Registry status
400
Enrollment target
1
Study location

NCT06883227: Recruiting study of Neurologic Disorder and Red Tide, sponsored by Roskamp Institute.

NCT06883227 is a study of Neurologic Disorder and Red Tide that is actively recruiting participants, run by Roskamp Institute. The registered enrollment target is 400 participants, below the 17,132-participant average among 12 other Neurologic Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06883227, a study of Neurologic Disorder and Red Tide, is actively recruiting participants, sponsored by Roskamp Institute.

RECRUITING
Registry status
400 participants
Enrollment target
1
Study location

Study Summary

The goals of this project are to study the biological effects of environmental toxins (ET), in particular aquatic toxins such as brevetoxins (PbTx) and microcystin or their metabolites. This study is designed to examine the effects of the body from harmful algae blooms (HAB) as well as possibility of an association between exposure to the marine toxin, brevetoxin (PbTx), which is released from K. brevis during the red tide bloom, and the prevalence of neurological illnesses.

Primary Outcome

The Investigators want to examine the effects of the body from harmful algae blooms (HAB) as well as possibility of an association between exposure to the marine toxin, brevetoxin (PbTx), which is released from K. brevis during the red tide bloom, and the prevalence of neurological illnesses. Height and weight will be combined to assess BMI (BMI = weight (lb) ÷ height2 (inches))

Conditions Studied

Neurologic Disorder Red Tide Florida

Study Locations (1)

Florida

  • The Roskamp Institute - Sarasota

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2024-10-14
Est. Completion 2030-10-14
Roskamp Institute

7 total trials

What NCT06883227 shows while recruiting

NCT06883227 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 17,132-participant average among 12 other Neurologic Disorder trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Neurologic Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT06883227 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06883227 about?

NCT06883227 is a clinical study titled "Investigating Health Impacts of Exposure to Harmful Algal Blooms". The goals of this project are to study the biological effects of environmental toxins (ET), in particular aquatic toxins such as brevetoxins (PbTx) and microcystin or their metabolites. This study is designed to examine the effects of the body from harmful algae blooms (HAB) as well as possibility o...

What is the current status of trial NCT06883227?

This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2024-10-14. Estimated completion is 2030-10-14.

What conditions does trial NCT06883227 study?

This clinical trial studies the following conditions: Neurologic Disorder, Red Tide, Florida.

Who is sponsoring clinical trial NCT06883227?

This trial is sponsored by Roskamp Institute, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06883227 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Neurologic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06883227's enrollment target sits among peer trials

400 7th of 12 higher than 6 of 12 other Neurologic Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Neurologic Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02108054 · 400 participants · NA

    Behavioral and Functional Task Development, Implementation, and Testing

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06883227

Source: ClinicalTrials.gov NCT06883227, the US trial registry maintained by the National Library of Medicine. NCT06883227 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.